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Abstract
We report analyses of a Brazilian study of early onset schizophrenia (BEOS) families. We genotyped 22 members of 4 families
on a linkage SNP array and report here non-parametric linkage analyses using MERLINH software. We found suggestive
evidence for linkage on two chromosomal regions, 13q32 and 11p15.4. A LOD score of 2.71 was observed at 13q32 with a
one LOD interval extending from 60.63–92.35 cM. From simulations, this LOD score gave a genome-wide empirical
corrected p= 0.33, after accounting for all markers tested. Similarly 11p15.4 showed the same maximum LOD of 2.71 and a
narrower one LOD interval of 4–14 cM. Of these, 13q32 has been reported to be linked to schizophrenia by multiple
different studies. Thus, our study provides additional supporting evidence for an aetiological role of variants at 13q32 in
schizophrenia.
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Introduction
Schizophrenia is a chronic, highly disabling disease that has a
point prevalence estimate of ,0.5% general population, which
usually leads to persistent functional impairment with considerable
morbidity and economic cost [1,2]. It is considered a complex trait
resulting from both genetic and shared environmental etiological
influences. Several studies support a familial aggregation (as
reviewed by Sullivan [3]) with a 10-fold increase in risk to sibling
of one proband and up to a 40-fold increase when both parents are
affected [4]. The genetic contribution to risk is high and
heritability estimates based on clinical ascertainment are usually
given as over 80% [5,6]. A recent population-based study of 2
million families in Sweden put the estimate at a lower, but still
considerable, 64.3%, with a 95% Confidence Interval (C.I.)
estimate of 61?7%–67?5% [7].
Linkage analysis is a standard approach for identifying the
location of genes that cause genetic diseases [8], whose primary
advantage lies in detecting genes of moderate to major effect. This
contrasts with genome-wide association studies, which are superior
at finding loci of small effect [9]. Linkage studies conducted in
schizophrenia have yielded positive findings in many different
regions of the genome, with a somewhat confusing mixture of
replication and non-replication. There is clear heterogeneity with
no ‘hard’ replication for any region, with none being implicated in
more than 20% independent studies [3].
Several reasons may explain these results, including locus and
phenotypic heterogeneity, inadequate sample size, differences in
ascertainment, marker sets, ancestry and statistical methods [10].
A systematic genome-scan meta-analysis [11] found 20 regions
that achieved genome-wide linkage evidence. In a recent update of
their meta-analysis that included 32 genome-wide SCZ studies, 10
regions were identified, with a concordant finding for the two
meta-analysis on chromosome 2q (118.7–152 Mb) [10]. More
specifically, they found that 10 genome bins are likely to contain
loci linked to SCZ, including regions of chromosomes 1q, 2q, 3q,
4q, 5q, 8p and 10q. In a secondary analysis of 22 studies of
European-ancestry samples, they reported suggestive evidence for
linkage on chromosome 8p. Other loci have been reported and
replicated in two regions of chromosome 13, one in the region of
13q21–33, (, 95 Mb) and another in the 13q13–14 region (,
40 Mb) [12–17].
In the present study we perform a pilot linkage study in
Brazilian families with early-onset schizophrenia in Sao Paulo,
Brazil. We report here the results of non-parametric linkage
analyses in 4 small multiplex families.
Methods
Ethics Statement
This study was approved by Research Ethics Committee of
UNIFESP [CEP No. 1737/06]. Written informed consent was
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obtained from all participants recruited or caregivers, on the
behalf of minors/children, and, clinical and laboratory investiga-
tions were strictly conducted according to the principles expressed
in the Declaration of Helsinki. All subjects invited accepted to
enroll this study.
Ascertainment of BEOS Families
22 subjects from 4 families, including 11 patients with
schizophrenia and 1 with schizoaffective disorder were ascer-
tained, yielding 8 affected sib-pairs and 6 other affected relative-
pairs. All patients were being treated at the same specialized
outpatient clinic in Sao Paulo, Brazil. Eligibility criteria were: one
or more affected members with age of onset ,18 years, and to
have two or more members diagnosed with schizophrenia,
excluding monozygotic twins. Exclusion criteria were comorbid
mood disorders, mental retardation, and inability in providing
informed consent.
Clinical Assessment
The Structured Diagnostic Interview (SCID) was performed by
trained psychiatrists to provide DSM-IV psychiatric diagnosis.
Individuals under 18 years old were assessed with the Kiddie–
Sads-Present and Lifetime Version [18]. The patients were also
evaluated with the Positive and Negative Syndrome Scale
(PANSS), Calgary Depression Scale [19], Clinical Global Impres-
sion (CGI), and Global Assessment of Functioning (GAF)
instruments [20]. For the diagnosis, all available information,
including medical record and family informant unstructured data,
was used. When there was any doubt about the diagnosis, even for
subtype, the interview and the medical records were reviewed by
two other trained psychiatrists. There were 2 dubious cases, for
subjects 41 and 42 in family 2. For subject 41 the doubt was
whether best diagnosis would be schizoaffective disorder or
schizophrenia. After careful consideration, we decided for
schizoaffective disorder. For subject 42 the doubt was whether
the number of symptoms and severity would allow the diagnosis of
schizophrenia. After reevaluation we decided on the diagnosis of
‘psychosis not otherwise specified’.
Clinical Demographics and Family Structures
The mean age of the whole sample was 41.4 (sd = 16.2); 43.5
(sd = 18.8) for non-affected individuals, and 39.7 (sd = 14.29) for
patients. This difference was non-significant (Mann-Whitney
U=52.500; p = 0.62). For the whole sample, 54.5% are male
and 45.5% are female; there was no significant difference in
gender proportion between affected and non-affected individuals
(Chi-square value = 1.56; p = 0.21). 7 out of 12 affected individuals
presented onset age #18 years old, with a mean age of 15.57
(sd = 2.1). The 5 other affected subjects had a mean age of onset of
24.20 (sd = 4.6). A brief description of each family and the
respective pedigree diagrams are provided in the figures below
(Fig. 1–4):
DNA Isolation and Quantification
Whole blood was collected into tubes containing 0.1% EDTA
and genomic DNA isolation was performed using the GentraTM
PuregeneTM Kit (Qiagen, Maryland, USA), according to the
manufacturer’s protocol. DNA concentration was measured using
a spectrophotometer (ND-1000 NanoDropH Technologies, Wil-
mington, USA) and each sample was accurately quantified in
triplicate and diluted to 10060.5 ng/mL. Genotyping was
performed using standard methods at laboratories at the MRC
SGDP Centre, KCL. Briefly, Affymetrix 10 k arrays were typed in
Figure 1. Family 1 - Three individuals affected with paranoid, treatment-resistant schizophrenia were enrolled. Father probably
affected as reported by other family members but had no lifetime diagnosis. Another sibling, with a clear history of psychotic symptoms, committed
suicide.
doi:10.1371/journal.pone.0052262.g001
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all samples and genotypes were called as per the manufacturer’s
protocol.
Family Linkage Analysis
All phenotypic information from interviews and questionnaires
was coded and samples were assigned a number with removal of
any personal identifying information. The program MERLIN [21]
was used to perform non-parametric dichotomous linkage analysis.
Map distances were provided by the annotation files supplied with
the array. Allele frequencies were estimated using the maximum
likelihood option in MERLIN using the entire sample. Merlin
multipoint LOD scores were calculated at each marker and 10
positions between them. Specifically we used MERLIN’s –exp call
to derive Whittemore and Halpern NPL pairs Z scores [22] under
the exponential model, which allows for extreme allele sharing and
which is more accurate in analyses of small collections of families.
MERLIN converts these Z-scores into LOD scores using the
method of [23]. Relationships were checked using the program
GRR [24]. PEDSTATS [25] was used to detect mendelization
errors. In addition the –error procedure was used to remove
unlikely recombinants, while the –simulate procedure was used to,
empirically, estimate the false positive rate (1000 simulations).
Details of each family are show in figures 1–4.
Results
Linkage Results
We found a suggestive linkage with a LOD score of 2.71 at
13q32 at 13q31/32 (Figure 5). The peak is broad with a one LOD
interval extending from 60.63–92.35 cM (flanking markers
rs723801 and and rs1323619). From simulations this LOD score
gave a genome-wide empirical corrected p= 0.33 (uncorrected
p= 0.0002062) accounting for all markers tested. Similarly
11p15.4 showed the same maximum LOD of 2.71 with a
corrected p= 0.33 (uncorrected = 0.0002067) and a narrower
one LOD interval of 4–14 cM (flanking markers rs720571 and
rs2132517). One other region gave a LOD score .2 with a LOD
of 2.45 on 19p13.3. The one-LOD interval spanned 5.6 and
11.8 cM but was supported by only 3 SNPs (rs2108389,
rs1384936, rs639251) and did not exceed out suggestive linkage
threshold derived from simulations of 2.57.
Discussion
In our study we found suggestive evidence for linkage on
chromosomal regions 13q32 and 11p15.4 under the criteria of
Lander and Kruglyak [26]. The former region has already been
implicated in several studies [OMIM SCZ7%603176]. Blouin
et al. [13] reported a non-parametric linkage (NPL) analysis
providing significant evidence for an SSL on chromosome 13q32
(NPL score = 4.18; p = 0.000002), and suggestive evidence for
another SSL on chromosome 8p21–22 (NPL=3.46; p = 0.0001).
This replicated the earlier finding of a LOD score of 1.61 for
marker D13S144 by Lin et al. [12]. Brzustowicz et al. [27]
analyzed 21 Canadian families with schizophrenia and found
genome-wide significant LOD scores on 13q. Brzustowicz et al.
[28], using the same dataset and multipoint analysis and found a
maximum LOD score of 3.81 with an empirical p = 0.02 under a
Figure 2. Family 2 - Five individuals affected enrolled: 2 paranoid, 1 hebephrenic, 1 schizoaffective and 1 with a DSM-IV diagnosis
of psychosis not otherwise specified, probably an schyzotypal personality disorder. Both sides present history of schizophrenia over
generations with no relation between them. In both sides there is also high incidence of cancers (retinoblastoma and brain tumors).
doi:10.1371/journal.pone.0052262.g002
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recessive-broad model of schizophrenia at D13S793, with an
estimated 65% of families linked to this region. Faraone et al. [15]
assessed linkage between 13q and schizophrenia in 166 families.
They found a suggestive maximum LOD score was 1.43 (Z-score
of 2.57) at 79.0 cM with the peak being within 3 cM of the peak
reported by Brzustowicz et al. [27]. Mulle et al. [29] reported a
nonparametric linkage score in a sample of 29 sib-pairs with
schizophrenia of 2.95 at D13S174, the same marker at which
Blouin et al. [13] reported their maximum LOD.
Chromosome 11 includes several plausible candidate genes for
major psychiatric disorders, especially psychosis, including the
tyrosine hydroxylase (TH) and the dopamine receptor D4 (DRD4)
(both at 11p15). However, the evidence for linkage in the region is
weak. A review of the linkage results in the region concluded that
they show a lack of replication but suggested that modest interest
was maintained by possible signals scattered across a 30cM
interval [30]. Some more recent studies found evidence for a role
of chromosome 11p15.4 in bipolar disorder [31] autism [32] and
attention deficit hyperactivity disorder [33].
This relative lack of previous evidence for chromosome 11p15
contrasted with the strong previous findings available for 13q32.
Thus, although we should not disregard the linkage with 11p15.4,
our primary finding is an additional evidence for a potential role
for 13q32 region in a small Brazilian sample of families with early-
onset schizophrenia affected individuals. The allele-sharing model
tested is compatible with allelic homogeneity within the families.
This region encompasses several genes, some of them already
investigated in schizophrenia but with predominantly negative
results like ZIC2, SLC15A1, and FGF14. Goes et al. [34] showed
evidence for familial aggregation to mood incongruent psychotic
symptoms among patients with bipolar disorder for 13q32 region.
Other studies have reported association with the nearby 13q13–14
region (i.e., [17]). However, recent large schizophrenia GWAS
analyses have failed to report significant association in both regions
[35] and there are no obvious known variants that explain the
observed linkage signal [10].
Figure 3. Family 3 - Two individuals affected enrolled, but clear evidence of other cases in previous generations. Both cases are
paranoid schizophrenia, but with mild functional impairment and good response to antipsychotic treatment.
doi:10.1371/journal.pone.0052262.g003
Figure 4. Family 4 - Both siblings affected with severe
functioning impairment. Father probably affected but with no
definite diagnosis and with no contact to the family.
doi:10.1371/journal.pone.0052262.g004
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The major limitation of our study was the small sample size.
However, families with early-onset schizophrenia were ascertained
in an attempt to focus on a more severe and homogenous form of
the illness. Likewise, although we find replication evidence for
13q32 and schizophrenia, the most recent meta-analysis [10]
failed to yield significant results for this region, suggesting that
there may be significant locus heterogeneity between studies and
that, if this is a true linkage, then only a subset of families and
cohorts show the effect. It should also be noted that this replication
was not the primary aim of the study, which was exploratory.
Another caveat relates to the probable genetic heterogeneity
between families in regard to which individuals provided DNA.
This could be an issue, but our primary method of analysis derives
its information from the affected rather than the unaffected
individuals.
Further analyses of family based early onset schizophrenia
cohorts and large scale sequencing efforts may shed further light
on the specific genetic factors influencing risk for schizophrenia in
this region.
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